Blockade of Mycn in neuroblastoma
|
University of California San Francisco / William Weiss |
Innovation Grants |
2008 |
California |
A Pilot Study of the Feasibility and Acceptability of an Interactive Computerized Symptom Assessment Tool to Assess Disease and Treatment-Related Symptoms Experienced by Children with Cancer |
University of California San Francisco / Tina Baggott, RN, PhD, PNP |
Nurse Researcher Grants |
2009 |
California |
Single Cell Analysis of Leukemia Initiation |
Stanford University / Michael Cleary, MD |
Innovation Grants |
2015 |
California |
Predicting Outcome for Patients with Metastatic Neuroblastoma by Analysis of Bone Marrow and Blood for a Neuroblastoma Gene Expression Signature |
Children’s Hospital Los Angeles / Robert Seeger |
Innovation Grants |
2010 |
California |
Determinants of Testicular Germ Cell Tumor Platinum Sensitivity and Resistance |
University of California, San Diego / Paolo Abada |
Young Investigator Grants |
2012 |
California |
A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG) |
Stanford University / Michelle Monje, MD, PhD |
'A' Award Grants |
2011 |
California |
Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma |
Children’s Hospital Los Angeles / Shahab Asgharzadeh, MD |
Innovation Grants |
2015 |
California |
Saving Lives, Saving Neurons, the Head Start Consortium for Young Children with Malignant Central Nervous System Tumors
|
Children’s Hospital Los Angeles / Jonathan Finlay, MD |
Phase I/II Infrastructure Grants |
2007 |
California |
Targeting inhibitory phosphatase signaling in high-risk childhood ALL |
University of California San Francisco / Markus Muschen, MD, PhD |
Innovation Grants |
2011 |
California |
GD2-directed CAR T cell therapy for H3K27M+ spinal cord diffuse midline glioma |
Board of Trustees of the Leland Stanford Junior University / Michelle Monje |
Catalyst Grants |
2021 |
California |